The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue

This publication has 13 references indexed in Scilit:

• Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
  Circulation Research, 1994
• Cardiovascular Profile of Ro 40–5967, a New Nondihydropyridine Calcium Antagonist, Delineated in Isolated, Blood-Perfused Dog Hearts
  Journal of Cardiovascular Pharmacology, 1993
• Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
• Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy
  European Journal of Pharmacology, 1991
• Ro 40–5967: A New Nondihydropyridine Calcium Antagonist
  Cardiovascular Drug Reviews, 1991
• In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic Action
  Journal of Cardiovascular Pharmacology, 1989
• Substituted Diphenylbutylpiperidines Bind to a Unique High Affinity Site on the L-type Calcium Channel
  Published by Elsevier ,1989
• A practical computer-based approach to the analysis of radioligand binding experiments
  Computer Programs in Biomedicine, 1983
• Temperature‐dependent regulation of d‐cis‐[³H]diltiazem binding to Ca²⁺ channels by 1,4‐dihydropyridine channel agonists and antagonists
  FEBS Letters, 1983
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976